2017 Section 7 Green Book

quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 2008;26:3770–3776. 32. Reeve BB, Cai J, Zhang H, et al. Health-related quality of life differences between African Americans and non-Hispanic whites with head and neck cancer. Head Neck 2013;35:1255–1264. 33. Divaris K, Olshan AF, Smith J, et al. Oral health and risk for head and neck squamous cell carcinoma: the Carolina Head and Neck Cancer Study. Cancer Causes Control 2010;21:567–575. 34. D’Antonio LL, Zimmerman GJ, Cella DF, Long SA. Quality of life and functional status measures in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 1996;122:482–487. 35. List MA, D’Antonio LL, Cella DF, et al. The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Can- cer Therapy-Head and Neck Scale. A study of utility and validity. Can- cer 1996;77:2294–2301. 36. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570–579. 37. Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 2003;1:79. 38. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002;77:371–383. 39. VanderWalde NA, Fleming M, Weiss J, Chera BS. Treatment of older patients with head and neck cancer: a review. Oncologist 2013;18:568– 578. 40. Fenn KM, Evans SB, McCorkle R, et al. Impact of financial burden of can- cer on survivors’ quality of life. J Oncol Pract 2014;10:332–338. 41. Rao D, Debb S, Blitz D, Choi SW, Cella D. Racial/Ethnic differences in the health-related quality of life of cancer patients. J Pain Symptom Man- age 2008;36:488–496. 42. Utsey SO, Chae MH, Brown CF, Kelly D. Effect of ethnic group member- ship on ethnic identity, race-related stress, and quality of life. Cultur Divers Ethnic Minor Psychol 2002;8:366–377. 43. Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P. Quality of life and oral function in patients treated with radiation ther- apy for head and neck cancer. Head Neck 2001;23:389–398. 44. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a system- atic review. Cancer Epidemiol Biomarkers Prev 2005;14:467–475. 45. Penner JL. Psychosocial care of patients with head and neck cancer. Semin Oncol Nurs 2009;25:231–241.

17. Potash AE, Karnell LH, Christensen AJ, Vander Weg MW, Funk GF. Con- tinued alcohol use in patients with head and neck cancer. Head Neck 2010;32:905–912. 18. Kugaya A, Akechi T, Okuyama T, et al. Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer 2000;88:2817–2823. 19. Aarstad AK, Lode K, Larsen JP, Bru E, Aarstad HJ. Choice of psychologi- cal coping in laryngectomized, head and neck squamous cell carcinoma patients versus multiple sclerosis patients. Eur Arch Otorhinolaryngol 2011;268:907–915. 20. Elani HW, Allison PJ. Coping and psychological distress among head and neck cancer patients. Support Care Cancer 2011;19:1735–1741. 21. Hammerlid E, Silander E, Hornestam L, Sullivan M. Health-related qual- ity of life three years after diagnosis of head and neck cancer—a longitu- dinal study. Head Neck 2001;23:113–125. 22. de Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA. Long-term quality of life of patients with head and neck cancer. Laryngoscope 2000;110:98–106. 23. Agarwal M, Hamilton JB, Crandell JL, Moore CE. Coping strategies of African American head and neck cancer survivors. J Psychosoc Oncol 2010;28:526–538. 24. Hammerlid E, Bjordal K, Ahlner-Elmqvist M, et al. A prospective study of quality of life in head and neck cancer patients. Part I: at diagnosis. Laryngoscope 2001;111:669–680. 25. Bjordal K, Ahlner-Elmqvist M, Hammerlid E, et al. A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data. Laryngoscope 2001;111:1440–1452. 26. Terrell JE, Ronis DL, Fowler KE, et al. Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2004;130:401–408. 27. Abendstein H, Nordgren M, Boysen M, et al. Quality of life and head and neck cancer: a 5 year prospective study. Laryngoscope 2005;115:2183– 2192. 28. Hughes PJ, Scott PM, Kew J, et al. Dysphagia in treated nasopharyngeal cancer. Head Neck 2000;22:393–397. 29. Chambers MS, Garden AS, Kies MS, Martin JW. Radiation-induced xero- stomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck 2004;26:796–807. 30. Jensen K, Jensen AB, Grau C. A cross sectional quality of life study of 116 recurrence free head and neck cancer patients. The first use of EORTC H&N35 in Danish. Acta Oncol 2006;45:28–37. 31. Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ. Impact of late treatment-related toxicity on

Reeve et al.: Factors Associated With Quality of Life

136